← Back to Patent Explorer
US4175128A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for treating congestive heart failure

Assignee: Pfizer Inc
•
Filing: 1979-01-03
•
Granted: 1979-11-20
•
Expires: 1999-01-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for the treatment of congestive heart failure in humans using pirbuterol or pharmaceutically acceptable acid addition salts thereof.

Inventors

  • 👤 Colin R. Taylor

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 06:55
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61P; A61P9/00; A61P9/04

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 47 words
A method of treating congestive heart failure in a human subject having such condition which comprises administering orally, parenterally or by inhalation to said human subject a congestive heart failure treating amount of a compound of the formula: ##STR3## or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim 47 words
A method of treating congestive heart failure in a human subject having such condition which comprises administering orally, parenterally or by inhalation to said human subject a congestive heart failure treating amount of a compound of the formula: ##STR3## or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 12 words
The method according to claim 1 wherein said compound is administered orally.
Claim 4
Dependent Claim 12 words
The method according to claim 1 wherein said compound is administered parenterally.
Claim 5
Dependent Claim 12 words
The method according to claim 3 wherein said parenteral administration is intravenous.
Claim 6
Dependent Claim 13 words
The method according to claim 1 wherein said compound is administered by inhalation.
Claim 7
Dependent Claim 14 words
The method according to claim 1 wherein said acid addition salt is the dihydrochloride.
Claim 8
Dependent Claim 14 words
The method according to claim 1 wherein said acid addition salt is the monoacetate.

References Cited (Backward Citations)

US3700681A Cited
US3948919A Cited
US4053605A Cited
US4061756A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-11-19 1983-05-21 1983-11-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-11-19 1987-05-21 1987-11-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-11-19 1991-05-21 1991-11-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag